FINE-HEART - Participant-level pooled analysis of finerenone in heart failure and chronic kidney disease trials - report from ESC2024

Professor Muthiah Vaduganathan explains that the FINE-HEART pooled analysis of three large trials failed to demonstrate significant reductions in cardiovascular death with finerenone, but significantly lower all-cause mortality, cardiovascular events and kidney outcomes were observed, according to late-breaking research presented in a Hot Line session at ESC Congress 2024. Video: https://medicaldigest.org/scientific-contents/interview:fine-heart-participant-level-pooled-analysis-finerenone-heart-failure-and-chronic-kidney-disease-trials